An interventional study of Balance training in Ankle Inversion Sprain, Instability, Joint and Treatment, sponsored by University Ghent. Completed. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2021-12-01.
Sponsored by University Ghent · Not applicable, Interventional, and Treatment
The goal of this study is evaluate the effect of uni-axial versus multidirectional balance training on muscle reaction time in subjects with chronic ankle instability. Muscle reaction time is measured on a trapdoor simulating an inversion sprain before and after a 6 week lasting balance training protocol.
115 studies on the registry are indexed under Joint Instability; 21 are open to participants now.
This study's enrollment of 60 is above the median of 46 across 58 interventional studies indexed under Joint Instability.
Browse Joint Instability studies →University Ghent is the lead sponsor of 350 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
According to the consensus statement of the International Ankle Consortium
Inclusion Criteria:
Exclusion Criteria:
Subjects in this group perform exercises on an uni-axial balance board
Other: Balance training
Subjects in this group perform exercises on a multidirectional balance board
Other: Balance training
6 weeks lasting balance training program
muscle reaction time
Muscle reaction of lower leg muscles is recorded during sudden simulated inversion sprain on a trap door
Time frame: 6 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.